back to US directory
us clinical guidance

Alcohol misuse and alcohol use disorder

VA/DoD-aligned screening, diagnostic assessment, withdrawal triage, evidence-based treatment and longitudinal harm reduction.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults with unhealthy alcohol use, possible alcohol use disorder or a request for treatment. The 2021 VA/DoD guideline covers screening, treatment and stabilization or withdrawal. Acute poisoning, pregnancy, adolescents, severe liver disease and polysubstance withdrawal need additional protocols and expertise.
sources for this section:VA/DoD SUD 2021

The Bottom Line

  • Use a validated alcohol screen in general medical care and follow a positive result with a diagnostic assessment of consumption, impaired control, consequences, tolerance, withdrawal and patient goals.
  • Offer brief intervention for unhealthy use and evidence-based psychosocial and pharmacologic treatment for alcohol use disorder without requiring repeated failure or abstinence before care begins.
  • Estimate withdrawal risk from current symptoms, prior severe withdrawal, seizures or delirium, amount and timing of use, medical illness and concurrent sedative use; a blood alcohol result alone does not establish safety.
  • Treat alcohol use disorder as a chronic condition with planned follow-up, relapse prevention, harm reduction and rapid re-engagement after recurrence rather than a single detoxification event.
sources for this section:VA/DoD SUD 2021

Practical clinical workflow

1
Ask nonjudgmentally about standard drinks, binge pattern, last use, morning use, prior withdrawal, treatment, driving, injuries, work and relationships, pregnancy possibility and other substances or medicines.
2
Assess diagnostic criteria, motivation, supports, housing, suicide risk, cognition, nutrition, liver and cardiovascular status and obtain targeted laboratory testing without using normal results to rule out disorder.
3
Match setting and treatment intensity to withdrawal and psychosocial risk; discuss appropriate medications for alcohol use disorder after checking opioid exposure, liver and kidney function, pregnancy and interactions.
4
Create a continuing plan for behavioral treatment, medication adherence, recovery or peer support if desired, primary care, vaccination, liver care, nutrition and reassessment after lapses.
sources for this section:VA/DoD SUD 2021

Safety boundaries and escalation

  • Seizure, delirium, hallucinations with autonomic instability, severe agitation, persistent vomiting, unstable vital signs or significant medical or psychiatric illness requires emergency or monitored withdrawal care.
  • Abrupt unsupervised cessation can be dangerous in a person with physiologic dependence; determine withdrawal risk and level of care before simply advising immediate abstinence.
  • Assess suicidal thinking, violence, neglect, unsafe driving, child or vulnerable-person safety and access to lethal means directly, especially during intoxication, withdrawal and major loss.
  • Do not combine alcohol with opioids, benzodiazepines or other sedatives; check medication-specific contraindications and do not use detoxification alone as definitive alcohol-use-disorder treatment.
sources for this section:VA/DoD SUD 2021VA/DoD suicide risk 2024

Localization

VA/DoD provides a US federal framework, while withdrawal facilities, state involuntary-treatment law, addiction coverage and medication formularies differ. SAMHSA and local systems can support linkage.
sources for this section:VA/DoD SUD 2021

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. U.S. Department of Veterans Affairs and U.S. Department of Defense Evidence-Based Practice Work GroupVA/DoD Clinical Practice Guideline for the Management of Substance Use DisordersVersion 4.0 (2021); official guideline page checked 2026-08-20 路 published 2021-08-01 路 accessed 2026-08-20
    view source
  2. U.S. Department of Veterans Affairs and U.S. Department of Defense Evidence-Based Practice Work GroupVA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide2024 guideline; official guideline page checked 2026-08-20 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.